Xylocaine From App Pharms With Lidocaine Hydrochloride 2%

Ingredients: Lidocaine Hydrochloride
Dosage Form and Administration: Jelly; Topical
Drug Trade Name: Xylocaine
Firm: App Pharms
Strength: 2%
New Drug Application Type: N
Drug Application Number:8816
Product Number: 1
Approval Date: 1/1/1982
Reference Listed Drug: Yes
Type: RX
Applicant Full Name: App Pharmaceuticals Llc

This is the Government on Crack

The war of drugs is now four-decades old. President Nixon started the campaign in 1971. After thousands of deaths, millions of arrests and billions of tax dollars spent, drug prohibition remains solidly intact despite fervent debate contesting the effectiveness of this now forty-year old policy.
A recent report by LEAP, the Law Enforcement Against Prohibition, details how the current administration policies continue to do more harm than good despite the Obama rhetoric to the contrary. LEAP members consist of current and former local, state and federal law enforcement agencies that have battled the war on drugs. According to former Baltimore narcotics officer and LEAP director, Neil Franklin, the United States jails more people than any other country in the world, making nearly two million drug arrests a year.

Drug Czar

The Obama administration and his drug czar, Gil Kerlikowske, the head of the Office of National Drug Control Policy, now devote more resources to policing than prevention. The 2004 federal drug budget was split 55 percent for supply reduction, policing and 45 percent for demand reduction, prevention and treatment. The 2012 Obama budget now has a 60 percent increase in policing while reducing prevention and treatment to 40 percent.
Obama rhetoric with regard to medical marijuana has been more talk than walk. During 8 years of the Bush administration there were about 200 federal raids, while under Obama there have already been about 100 raids in just two and a half years, notes LEAP.
The drug war only empowers the structures they purport to combat, reports former DEA agent, Sean Dunagan, who worked in Mexico and Guatemala. The illicit drug trade is big business and the prohibitionist model only turns a multi-billion dollar industry over to the criminal cartels. The huge profit incentive combined with powerfully resilient criminal organizations have shown that prohibition is a failure and alternatives need to be sought to address the problem of addiction as a social problem. While LEAP members acknowledge that ending prohibition will not defeat the drug cartels, it will decrease the power of the cartels.
The report by LEAP is only one of many that support ending prohibition for a four-decade old policy.

Sources: http://stopthedrugwar.org/chronicle/2011/jun/15/cops_say_forty_years_war_drugs_e
http://www.huffingtonpost.com/diane-dimond/we-need-a-new-drug-policy_b_881418.html

Continuity of Care

Continuity of care is essential for drug abusers re-entering the community. Drug users who complete treatment in prison and continue with treatment in the community have low relapse rates. Continuing drug abuse treatment helps released offender deal with problems that become relevant only after prison, such as learning to handle situations that could lead to relapse, learning how to live without drugs in the community and how to develop a peer support network. Treatment in prison or jail can begin a process of therapeutic change, resulting in reduced drug use and criminal behavior after incarceration. Continuing drug treatment in the community is essential to sustaining abstinence.

Balanced Approach

A balance of rewards and sanctions encourages positive social behavior and treatment participation. When providing correctional supervision of individuals participating in drug abuse treatment, it is important to reinforce positive behavior. Nonmonetary social rewards such as recognition for progress or sincere effort are effective, as are graduated sanctions that are consistent, predictable and clear responses to noncompliant behavior. Generally, treatment specialists implement less punitive responses for early and less serious noncompliance, with increasingly severe sanctions issued for continued problem behavior. Rewards and sanctions are most likely to have the desired effect when they are fair and when they swiftly follow the targeted behavior.